Parkinson's Disease (Jan 2021)

Characterizing Advanced Parkinson’s Disease: Romanian Subanalysis from the OBSERVE-PD Study

  • Jozsef Attila Szasz,
  • Dragos Catalin Jianu,
  • Mihaela Adriana Simu,
  • Viorelia Adelina Constantin,
  • Adriana Octaviana Dulamea,
  • Koray Onuk,
  • Diana Popescu,
  • Mihai-Titus Vasile,
  • Bogdan Ovidiu Popescu,
  • Alfonso Fasano,
  • Ovidiu Alexandru Bajenaru

DOI
https://doi.org/10.1155/2021/6635618
Journal volume & issue
Vol. 2021

Abstract

Read online

OBSERVE-PD was a cross-sectional, multicountry, observational study conducted in 128 Movement Disorders Centers (MDCs) in 18 countries. Overall, the study enrolled 2615 patients. The aim was to determine the proportion of patients with advanced Parkinson’s disease (APD) versus non-APD from MDCs and to uncover the clinical burden of APD, as well as a correlation between overall assessment of APD and several indicators of APD. The advanced stage of the disease and severity were assessed by investigators using their clinical judgement. Data were collected during a single visit between February 2015 and January 2016. Agreement on physician judgement of APD diagnosis and fulfillment of at least one previously established APD indicator was calculated. Motor and nonmotor symptoms (NMSs), activities of daily living, treatment complications, quality of life (QoL), conventional treatments, and device-aided therapy (DAT) eligibility were assessed. Here, country-specific results of 161 Romanian patients with PD are presented. In total, 59.0% of patients were diagnosed with APD and 78.8% met at least one APD indicator. There was only moderate agreement between clinical judgement of APD and overall fulfillment of APD indicators. All scores related to motor symptoms, NMSs, and treatment complications, as well as to QoL, showed a higher disease burden for patients with APD versus non-APD. Physicians considered 73.7% of patients with APD eligible for DAT. The majority of patients eligible for DAT (54.3%) did not receive such treatment. Our results highlight the importance of earlier recognition of APD, by combining clinical judgement with more standardized clinical tools, such as generally recognized APD criteria. However, timely diagnosis of APD alone is not enough to improve patient outcomes. Other critical factors include patient acceptance and access to appropriate treatment.